Menopausal hormone therapy;Terapia hormonal da menopausa

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 6, 2007, Pages 938-942

  Pardini, Dolores ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Climacterium; Hormone therapy; Menopause

Indexed keywords

EID: 35848944307     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000600007     Document Type: Short Survey

References (28)

1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al . Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
3. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002;287:2668-76.
4. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative Randomized Trial. JAMA 2003;290(3):1729-38.
5. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61.
6. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al.; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004;291(14):1701-12.
7. Lobo RA. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women. Arch Intern med 2004;164:482-4.
8. Hsia J, Langer R, Manson JE, Kuller L, Johnson KC, Hendrix SL, et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Int Med 2006;166(3):357-65.
9. Utian WH, Collins P, Ettinger B, Gallagher JC, Gass MLS, Gelfand MM, et al. Estrogen and progestogen use in peri and postmenopausal women: September 2003 position statement of The North American Menopause Society. Menopause 2003;10(6):497-504.
10. Skouby SO, Azzawi FA, Barlow D, Ertungealp JCAE, Gompel A, Graziottin A, et al. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri and postmenopausal hormone replacement therapy. Maturitas 2005;51:8-14.
11. Naftolin F, Schneider HPG, Sturdee DW. Guidelines for hormone treatment of women in the menopausal transition and beyond. Position Statement by the executive Committee of the International Menopause Society. Maturitas 2005;51:15-20.
12. Fernandes CE, Soares Pereira A, Machado RB, et al. Consenso da SOBRAC - Associação Brasileira de Climatério. Terapêutica hormonal na peri e na pós-menopausa. São Paulo 2004; Medcomm.
13. Clapauch R, Athayde A, Meirelles R, Weiss RV, Pardini DP, Leão LMC, et al.Terapia de reposição hormonal na menopausa .Posicionamento do Departamento de Endocrinologia Feminina e Andrologia da SBEM. Arq Bras Endocrinol Metab 2005;49(3):449-54.
14. Santoro NF, Clarkson TB, Freedman RR. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
15. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review). The Cochrane Library, Issue 1. Chichester: John Wiley & Sons, Ltd., 2004.
16. Cardozo L, Lose G, McClish D, Versi E, Koning GH. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15-20.
17. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women (Cochrane Review). The Cochrane Library, Issue 1. Chichester: John Wiley & Sons, Ltd., 2004.
18. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. [Position Statement] Menopause 2006;13(3):340-67.
19. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002;287:2668-76.
20. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose micronized 17α-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA 2003;290:1042-8.
21. Shumaker S, Legault C, Rapp S, Thal L, Wallace R, Robert B, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative memory study: A randomized controlled trial. JAMA 2003;289(20):2651-62.
22. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer disease. Lancet 1996;348:429-32.
23. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen Therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-95.
24. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement: scientific review. JAMA 2002;288:872-81.
25. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, et al. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998;19:604-21.
26. Boccardi M, Ghidoni R, Govoni S, Testa C, Benussi L, Bonetti M, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel based morphometry study. Menopause 2006;13(4):584-91.
27. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Harvard study of moods and cycles. Arch Gen Psychatry 2003;60:29-36.
28. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.